June 11, 2020 / 6:17 AM / 22 days ago

BRIEF-Biophytis: MHRA Approves UK COVA Trial With Sarconeos For COVID-19 Patients

June 11 (Reuters) - Biophytis SA:

* RECEIVES MHRA APPROVAL TO INITIATE THE COVA CLINICAL TRIAL IN THE UK WITH SARCONEOS (BIO101) FOR THE TREATMENT OF PATIENTS WITH COVID-19 RELATED RESPIRATORY FAILURE

* PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, ADAPTIVE AND GROUP SEQUENTIAL STUDY ASSESSING SARCONEOS(BIO101) IN PATIENTS INFECTED WITH SARS-COV-2 IS EXPECTED TO START IN COMING WEEKS IN UK Source text: bit.ly/2BWWTph Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below